Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Kindred Biosciences Announces Pricing of Public Offering
-
Galmed Pharma (GLMD) Prices 5M Share Common Offering at $15/Sh
-
Galmed Pharmaceuticals Ltd. Announces Pricing of Public Offering of Ordinary Shares
-
Orchid Island Capital Announces June 2018 Monthly Dividend and May 31, 2018 RMBS Portfolio Characteristics
-
Kindred Biosciences (KIN) to Offer Common Stock
-
Kindred Biosciences Announces Proposed Public Offering of Common Stock
-
Cantor Still Likes Valeant Pharma (VRX) Despite The CRL
-
Thunder Bridge Acquisition, Ltd. Announces Pricing of $225,000,000 Initial Public Offering
-
Valeant Pharmaceuticals (VRX) PT Raised to $32 at Cantor Fitzgerald
-
Galmed Pharma (GLMD) Proposed $75M Public Offering of Ordinary Shares
-
Galmed Pharmaceuticals Ltd. Announces Proposed Public Offering of Ordinary Shares
-
Centene (CNC) PT Raised to $137 at Cantor Fitzgerald
-
bluebird bio (BLUE) is Fundamentally Overvalued - Cantor
-
Verastem (VSTM) Capital Raise Removes Overhang - Cantor Fitzgerald
-
Prothena Corp (PRTA) PT Raised to $18 at Cantor Fitzgerald; 'To Reflect Restructuring'
-
U.S.-China trade fight leads stocks lower, oil sinks on supply fears
-
Max Sound Files Regulatory Complaints To Expose Manipulative Trading Practices and Abusive Naked Short Selling by Major Market Makers
-
ProPhotonix Secures �700,000 Term Loan - STKR
-
Explains Illegal Naked Shorting Being Perpetrated By Major Market Makers on MAXD Shares
-
Global Blood Therapeutics (GBT): Look For Efficacy Data From EHA Over The Next Two Days - Cantor
-
Max Sound Corporation Announces Short Squeeze Situation On Its Stock
-
STRATA Skin Sciences to Participate in Panel Discussion at Cantor Fitzgerald Dermatology & Aesthetics Summit
-
PellePharm to Participate in the Cantor Fitzgerald Dermatology and Aesthetics Summit
-
Majesco Entertainment (COOL) PT Lowered to $65 at Cantor Fitzgerald
-
Three Years in a Row: Makor Wins EXEL Title for Best Special Situations Sales
-
Pre-Open Movers 06/12: (GLMD) (RH) (PLAY) Higher; (IDRA) (JCAP) (IMMU) Lower (more...)
-
Evolus (EOLS) PT Raised to $35 at Cantor Fitzgerald
-
Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit
-
After-Hours Stock Movers 06/11: (RH) (PLAY) (PFNX) Higher; (JCAP) (IMMU) (HOME) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts AcelRx Pharmaceuticals (ACRX) at Overweight
-
UPDATE: Cantor Starts Collegium Pharmaceutical (COLL) at Outperform
-
Cantor Fitzgerald Starts Biohaven Pharmaceutical Holding (BHVN) at Overweight
-
Cantor Fitzgerald Starts ANI Pharmaceuticals (ANIP) at Overweight
-
Cantor Fitzgerald Starts Momenta Pharmaceuticals (MNTA) at Neutral
-
Cantor Fitzgerald Starts Eagle Pharmaceuticals (EGRX) at Overweight
-
Cantor Fitzgerald Starts Emergent BioSolutions (EBS) at Overweight
-
Cantor Fitzgerald Starts OPNET Technologies (OPNT) at Overweight
-
Freddie Mac Prices $814 Million Multifamily K-Deal, K-1505
-
U.S. stocks rise ahead of North Korea summit, despite Trump's G7 fireworks
-
Cantor Fitzgerald Reiterates Overweight on Allscripts (MDRX)
-
Cantor Fitzgerald Starts Eli Lilly (LLY) at Overweight
-
Cantor Fitzgerald Starts Pfizer (PFE) at Overweight
-
Jack Henry (JKHY) PT Raised to $141 at Cantor Fitzgerald
-
Athenahealth CEO steps down; company considers sale
-
U.S. judge throws out Nomura bond trader's conviction
-
Mike Won Joins White Oak Healthcare Finance to Bolster Origination Efforts
-
PolarityTE (COOL) Prices $55M Follow-on Offering of Common Stock
-
PolarityTE Announces Pricing of Public Follow-on Offering of Common Stock
-
PolarityTE Announces Pricing of Public Follow-on Offering of Common Stock
-
Coupa Software (COUP) PT Raised to $67 at Cantor Fitzgerald

